CAS No.
[202189-78-4 (Unlabeled)]
Therapeutic Uses
Antihistamine
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
4-[2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethylbenzeneacetic acid (ACI); 2-[-4-(2-[4-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl)phenyl]-2-methylpropanoic acid; Bilastine
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Bilastine-d6 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Bilastine-d6 usage and description
Bilastine D6 is a deuterated form of bilastine, which is a second-generation H1-receptor antagonist used for the treatment of allergic rhinitis and urticaria. Bilastine D6 is a stable isotope-labeled version of bilastine, which is commonly used in pharmacokinetic studies to evaluate the metabolism, distribution, and elimination of bilastine in the body.
Chemically, bilastine D6 has the same molecular formula as bilastine, which is C28H37N3O3S. The only difference is that six hydrogen atoms in bilastine are replaced with deuterium atoms in bilastine D6. Deuterium is a non-radioactive isotope of hydrogen that has a higher atomic mass, which makes it useful for studying drug metabolism and pharmacokinetics.
Bilastine D6 is typically administered orally in tablet form. It is rapidly absorbed in the gastrointestinal tract and reaches peak plasma concentrations within 1-1.5 hours after ingestion. Bilastine D6 undergoes extensive metabolism in the liver, primarily via cytochrome P450 enzymes, and is eliminated from the body mainly through urine and feces.
In conclusion, Bilastine D6 is a helpful tool for researchers and clinicians to gain a better understanding of the pharmacokinetics and metabolism of bilastine, which can ultimately improve the treatment of allergic rhinitis and urticaria.
